SCHEMBL2033548

SCHEMBL2033548

C(=Cc1ccccc1)Cc1cccc(CC=Cc2ccccc2)c1CC=Cc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 2/20 0.53
PTGER3 P43115 2/20 0.53
PTGER2 P43116 2/20 0.53
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 3/20 0.45
MAPT P10636 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
RECQL P46063 1/20 0.45
TP53 P04637 1/20 0.45
CYP3A4 P08684 1/20 0.45
ALOX15 P16050 1/20 0.45
IDO1 P14902 2/20 0.44
PAM P19021 1/20 0.44
HTR2A P28223 4/20 0.41
NR1I2 O75469 1/20 0.41
DRD2 P14416 1/20 0.41
ADRA2C P18825 1/20 0.41
CNR1 P21554 1/20 0.41
SLC6A2 P23975 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2033547 1.00 PTGER4 (0.53) PTGER4PTGER3PTGER2KDM4EALDH1A1
SCHEMBL24075642 0.82 PTGER4 (0.56) PTGER4PTGER3PTGER2KDM4EALDH1A1
SCHEMBL3128231 0.79 NFE2L2 (0.43) PTGER4PTGER3PTGER2KDM4EALDH1A1
SCHEMBL3128239 0.79 NFE2L2 (0.43) PTGER4PTGER3PTGER2KDM4EALDH1A1
SCHEMBL23527384 0.79 CYP1A2 (0.60) PTGER4PTGER3PTGER2KDM4EALDH1A1
SCHEMBL23527383 0.79 CYP1A2 (0.60) PTGER4PTGER3PTGER2KDM4EALDH1A1
SCHEMBL11875055 0.78 GABRA1 (0.44) PTGER4PTGER3PTGER2KDM4EALDH1A1
SCHEMBL15106904 0.78 PTGER4 (0.51) PTGER4PTGER3PTGER2KDM4EALDH1A1
SCHEMBL6546776 0.78 PTGER4 (0.56) PTGER4PTGER3PTGER2KDM4EALDH1A1
SCHEMBL1932534 0.78 ALDH1A1 (0.55) PTGER4PTGER3PTGER2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10696620-B2 Antimicrobial compounds BOULOS & COOPER PHARMACEUTICALS PTY LTD (AU) 2020-06-30 US disclosed
US-20180290963-A1 ANTIMICROBIAL COMPOUNDS BOULOS, RAMIZ (AU) 2018-10-11 US disclosed
US-9738591-B2 Antimicrobial compounds Boulos, Ramiz (AU) 2017-08-22 US disclosed
US-20170029359-A1 ANTIMICROBIAL COMPOUNDS THE UNIVERSITY OF WESTERN AUSTRALIA (AU) 2017-02-02 US disclosed
US-20150189873-A1 ANTIMICROBIAL COMPOUNDS BOULOS & COOPER PHARMACEUTICALS PTY LTD (AU) 2015-07-09 US disclosed
US-9023892-B2 Antimicrobial compounds Boulos, Ramiz (AU) 2015-05-05 US disclosed
US-20120329871-A1 ANTIMICROBIAL COMPOUNDS THE UNIVERSITY OF WESTERN AUSTRALIA (AU) 2012-12-27 US disclosed
WO-2011075766-A1 ANTIMICROBIAL COMPOUNDS THE UNIVERSITY OF WESTERN AUSTRALIA (AU) 2011-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180290963-A1 ANTIMICROBIAL COMPOUNDS MRPL21, SPOUT1, MPO PTGER4 4282/4885PTGER3 4490/4885PTGER2 4316/4885
US-10696620-B2 Antimicrobial compounds MRPL21, SPOUT1, MPO PTGER4 4282/4885PTGER3 4490/4885PTGER2 4316/4885
US-20120329871-A1 ANTIMICROBIAL COMPOUNDS DPM1, NACA, CLPP PTGER4 4438/4885PTGER3 4593/4885PTGER2 4377/4885
US-20170029359-A1 ANTIMICROBIAL COMPOUNDS MRPL21, SPOUT1, MPO PTGER4 4282/4885PTGER3 4490/4885PTGER2 4316/4885
US-20150189873-A1 ANTIMICROBIAL COMPOUNDS DPM1, NACA, CLPP PTGER4 4438/4885PTGER3 4593/4885PTGER2 4377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.